Try our beta test site

Treatment Optimization of Cetuximab in Patients With Metastatic Colorectal Cancer Based on Tumor Uptake of 89Zr-labeled Cetuximab Assessed by PET

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Laura Pijpers, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01691391
First received: May 15, 2012
Last updated: March 20, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2016
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):